CN1836705A - Medicine for treating amblyopia and its preparing method - Google Patents
Medicine for treating amblyopia and its preparing method Download PDFInfo
- Publication number
- CN1836705A CN1836705A CN 200510016658 CN200510016658A CN1836705A CN 1836705 A CN1836705 A CN 1836705A CN 200510016658 CN200510016658 CN 200510016658 CN 200510016658 A CN200510016658 A CN 200510016658A CN 1836705 A CN1836705 A CN 1836705A
- Authority
- CN
- China
- Prior art keywords
- medicine
- rhizoma
- amblyopia
- treatment
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The present invention discloses one kind of amblyopia treating medicine and its preparation process. Technologically, the amblyopia treating medicine is prepared with American ginseng, Chuanxiong rhizome, motherwort, wolfberry fruit, bupleurum root, haw, white atractylodes rhizome, cimicifuga rhizome and turtle shell as material, and through depurating, washing, drying and crushing into 120 mesh fine medicine powder, which may be further prepared into honeyed bolus or capsule. The amblyopia treating medicine has obvious curative effect.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of ophthalmic diseases, more particularly, is particularly children's myopia using of treatment amblyopia, and it is to be the Chinese patent medicine of feedstock production with pure Chinese medicine, and the present invention also reaches the preparation method that relates to its this medicine.
Background technology:
Amblyopia is a kind of common ophthalmic diseases, sickness rate is high, serious harm people are child's physical and mental health particularly, treats primary disease at present and still finds no good method, generally all adopts physiotherapy, as: magnetic therapy, black material hide, rub in the acupuncture point touches etc., though these therapies play certain therapeutical effect, can not eradicate, easily return bullet, and treatment time is long, and efficacy result is undesirable.
Summary of the invention:
The objective of the invention is to overcome the existing deficiency that the treatment amblyopia is particularly existed in the children's myopia using, a kind of medicine for the treatment of amblyopia is provided.
Another goal of the invention of the present invention provides the preparation method of the medicine of treatment amblyopia.
Solution of the present invention be based on Chinese medicine to ophthalmic diseases particularly to pathogenetic understanding of amblyopia and Therapeutic Principle, with reference to modern pharmacology, from Chinese medicine, filter out replenishing vital essence to improve eyesight, halo vision ear toot, natural animal-plant medicine such as the body resistance strengthening and constitution consolidating, blood-activating and qi-promoting, soothing liver-QI yang invigorating, by theory of Chinese medical science, monarch, minister, the combination principle of helping, making, carry out scientific composition, reach the purpose of treatment amblyopia.
Medicine of the present invention is made by following set of dispense, (consumption is a weight portion)
Radix Panacis Quinquefolii 10-20 Rhizoma Chuanxiong 10-20 Herba Leonuri 15-30 Fructus Lycii 25-30
Radix Bupleuri 10-20 Fructus Crataegi 20-40 Rhizoma Atractylodis Macrocephalae 20-25 Rhizoma Cimicifugae 15-30
Carapax Trionycis 20-30
Preparing Cui consumption weight (part) proportioning of medicine of the present invention is:
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20
The Rhizoma Atractylodis Macrocephalae 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20
The preparation method of medicine of the present invention is:
By its said medicine weight (part) proportioning, get crude drug, Radix Panacis Quinquefolii, Rhizoma Chuanxiong, Herba Leonuri, Fructus Lycii, Radix Bupleuri, Fructus Crataegi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Cimicifugae, Carapax Trionycis are removed impurity, cleaning, drying, crushing screening to 120 order fine powder, drug powder of the present invention.Drug powder of the present invention adds proper honey, can be made into honeyed pill, also can directly pour into glue and assist.
Radix Panacis Quinquefolii has effects such as strongly invigorating primordial QI, multiple arteries and veins take off admittedly, promoting the production of body fluid and inducing sedation of the mind in the medicine of the present invention; Rhizoma Chuanxiong has the effect of blood-activating and qi-promoting, wind-expelling pain-stopping; Herba Leonuri can be invigorated blood circulation, inducing diuresis to remove edema; Fructus Lycii energy nourishing the liver and kidney, replenishing vital essence to improve eyesight; Radix Bupleuri has the soothing liver-QI yang invigorating, evacuates the effect of bringing down a fever; Fructus Crataegi energy promoting digestion and invigorating the stomach, the circulation of qi promoting dissipating blood stasis; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, the effect of dampness diuretic; Rhizoma Cimicifugae has the effect of the rash of delivering, heat-clearing and toxic substances removing, and Carapax Trionycis has nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, brings down a fever to remove and steam.The present invention gives full play to the function of each drug effect, makes it reach the purpose of treatment amblyopia.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, selecting natural plant for use is raw material, does not add any additives, therefore, nontoxic to human body, have no side effect;
2, medicine of the present invention does not need special processing, makes the natural components of medicine not be damaged taking convenience;
3, wide accommodation is as all having significant curative effect and do not return bullet refractive amblyopia, congenital amblyopia, pseudomyopia, true and false mixed type myopia etc.;
Instructions of taking: if take powder child 5 gram/time, adult's 10 grams/time, day clothes 2 times, boiled water is taken after mixing it with water after meal.Taking pill or glue assists dose, method the same with taking powder.20 days is a course of treatment, and general patient can take effect a course of treatment, and can cure three courses of treatment.
The specific embodiment:
Press following proportioning weighting raw materials (kilogram):
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20 Rhizoma Atractylodis Macrocephalaes 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20
Production method is as follows:
With said medicine, remove impurity, cleaning, drying are pulverized, and are screened to 120 order fine powders, mix drug powder of the present invention.Drug powder of the present invention adds proper honey, can be made into honeyed pill, also can directly pour into glue and assist.
Claims (4)
1, a kind of medicine for the treatment of amblyopia is characterized in that it is the medicament of being made by following weight (part) proportion raw material
Radix Panacis Quinquefolii 10-20 Rhizoma Chuanxiong 10-20 Herba Leonuri 15-30 Fructus Lycii 25-30
Radix Bupleuri 10-20 Fructus Crataegi 20-40 Rhizoma Atractylodis Macrocephalae 20-25 Rhizoma Cimicifugae 15-30
Carapax Trionycis 20-30
2,, it is characterized in that the best proportioning of each crude drug weight (part) is according to claims 1 described a kind of medicine for the treatment of amblyopia
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20
The Rhizoma Atractylodis Macrocephalae 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20
3. according to claim 1,2 described a kind of weak medicines for the treatment of, it is characterized in that said medicament is a said dosage form on any pharmaceutics;
4, according to claims 2 described a kind of preparation methoies for the treatment of the medicine of amblyopia, it is characterized in that:
(1) get crude drug Radix Panacis Quinquefolii, Rhizoma Chuanxiong, Herba Leonuri, Fructus Lycii, Radix Bupleuri, Fructus Crataegi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Cimicifugae, Carapax Trionycis is removed impurity, cleaning, drying are crushed to 120 order fine powders, fully mix the back the powder of medicine of the present invention,
(2) promptly get the capsule of this medicine during above-mentioned powder is incapsulated, add proper honey, can be made into honeyed pill again.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100166582A CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100166582A CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1836705A true CN1836705A (en) | 2006-09-27 |
| CN100358552C CN100358552C (en) | 2008-01-02 |
Family
ID=37014299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100166582A Active CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100358552C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168575A (en) * | 2015-09-11 | 2015-12-23 | 胡庆丰 | Medicine for treating amblyopia ophthalmic diseases of children |
| CN105213620A (en) * | 2015-09-11 | 2016-01-06 | 胡庆丰 | A kind of medicine for the treatment of ophthalmic diseases |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1066945C (en) * | 1996-10-07 | 2001-06-13 | 郭书文 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
| CN1220161A (en) * | 1998-11-17 | 1999-06-23 | 梅唤群 | Specific drug for curing myopia |
-
2005
- 2005-03-24 CN CNB2005100166582A patent/CN100358552C/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105168575A (en) * | 2015-09-11 | 2015-12-23 | 胡庆丰 | Medicine for treating amblyopia ophthalmic diseases of children |
| CN105213620A (en) * | 2015-09-11 | 2016-01-06 | 胡庆丰 | A kind of medicine for the treatment of ophthalmic diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100358552C (en) | 2008-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102133378B (en) | Medicament for treating breast cancer | |
| CN101019975A (en) | Fracture treating Chinese medicine composition and its prepn | |
| CN1047946C (en) | Preparation for treating senile diseases | |
| CN1895556A (en) | Preparation for treating rheumatosis | |
| CN1562160A (en) | Composite medicine for treating hepatitis B complication | |
| CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
| CN1244373C (en) | Chinese medicinal composition for cholecystitis and preparing method thereof | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN100368001C (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
| CN102512632A (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN1129130A (en) | Medicament for treatment of cervical spondylopathy | |
| CN100450520C (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN109248305A (en) | A kind of Chinese medicine composition and preparation method thereof for treating liver fibrosis | |
| CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
| CN101095883A (en) | Oral medication for treating barrenness | |
| CN101024042A (en) | Medicine preparation for treating rheumatism disease by jointing Chinese medicine and western medicine | |
| CN1286500C (en) | Medication for treating numbness of the muscles and painful joints | |
| CN101549057A (en) | Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same | |
| CN102008635A (en) | Traditional Chinese medicine preparation for treating acute pancreatitis | |
| CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
| CN1410093A (en) | Medicine for treating cyst | |
| CN103041335A (en) | Traditional Chinese medicine composition for treating gastralgia | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN103028058B (en) | Traditional Chinese medicine composition for treating feebleness |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |